News brief­ing: Mer­ck picks up SHP2 op­tion from Tai­ho-As­tex deal; Taysha ex­pands part­ner­ship with UT South­west­ern

Tai­ho and As­tex have ex­tend­ed their col­lab­o­ra­tion with Mer­ck, grant­i­ng the phar­ma an ex­clu­sive li­cense to their joint SHP2 pro­gram.

Wednes­day’s ex­ten­sion stems from the agree­ment the three com­pa­nies signed in Jan 2020. Tai­ho and As­tex will re­ceive an undis­closed op­tion fee and be el­i­gi­ble for fur­ther undis­closed mile­stones and roy­al­ty pay­ments. Mer­ck will be sole­ly re­spon­si­ble for the glob­al de­vel­op­ment of the pro­gram and fund­ing all fur­ther re­search.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER